Klinic raises $24M Series A for specialty provider-enablement platform
What's the deal? Klinic, a Frisco, Texas-based startup, has raised $24M to build what it calls a Shopify-style digital platform for independent healthcare providers. Founded in 2021 by cofounder and chief executive officer Avish Bhama, the company initially focused on behavioural health but now spans 12 specialities, including oncology, cardiology, and rare disease.
The equity-only round, which began in January 2026, drew 34 investors. Backers listed on the company's website include Tau VenturesDealroom has a profile for this one. Try Dealroom →, Upstream VenturesDealroom has a profile for this one. Try Dealroom →, Proofpoint CapitalDealroom has a profile for this one. Try Dealroom →, Draper Associates, and Wicklow CapitalDealroom has a profile for this one. Try Dealroom →. Klinic has not disclosed how it plans to deploy the capital.
Why now? Independent specialist providers face a growing tangle of administrative burdens — from prior authorisations to revenue cycle management — that make it harder to compete with large health systems. Klinic bundles marketing, patient acquisition, intake software, electronic medical records, CRM tools, care coordination, and chart auditing into a single platform.
The company also runs a service line for speciality pharmaceutical firms, connecting hard-to-get medications with prescribers and patients. It operates alongside an affiliated provider group, Klinic Medical, through which patients can receive certain services directly.
What could go wrong? Key details remain thin. Klinic has not responded to press inquiries, and it is unclear which firms participated in this specific round versus earlier fundraises. Spanning 12 specialities — from behavioural health to gene therapy — is ambitious for a young company, and breadth can dilute focus.
Healthcare platform plays also face stiff competition from established electronic health record vendors and vertical SaaS companies already entrenched with providers.
The signal: Dealroom classifies Klinic as a "breakout"-stage company, yet it drew 34 investors to an equity-only round — notable breadth for a startup that has not publicly disclosed revenue metrics. The syndicate mixes healthcare-focused funds such as Proofpoint Capital with generalist venture names like Draper Associates, suggesting conviction that provider-enablement platforms can become a distinct vertical-SaaS category rather than a feature bolted onto existing EHR systems.
Read more: Behavioral Health Business
